Marinus Pharma (MRNS) Reports Q2 Loss of $0.46

Marinus Pharma (NASDAQ: MRNS) reported Q2 EPS of ($0.46), versus ($0.37) reported last year.

For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Zhen Ding Technology Holding Limited (4958:TT) (HASGF) PT Raised to NT$720 at Nomura/Instinet
• AeroVironment (AVAV) Tops Q4 EPS by 36c